NCT01973205 - Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine | Biotech Hunter

Enrollment

900

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Acute Migraine

Interventions

DRUG

Acetaminophen 250 mg and Aspirin 250 mg

2 tablets each containing Acetaminophen 250 mg and Aspirin 250 mg

DRUG

Placebo

2 placebo tablets matching acetaminophen 250 mg and aspirin 250 mg tablets

Trial Locations (19)

Birmingham

Anaheim

San Francisco

Fort Lauderdale

Jupiter

Oviedo

West Palm Beach

Evansville

Ann Arbor

Berlin

Rochester

The Bronx

Williamsville

Raleigh

Cincinnati

Cleveland

Mt. Pleasant

Salt Lake City

Kenosha